Subhash V. Kapre

666 citations

24 papers · 429 indexed · h-index 13

Co-authors: Prasad S. Kulkarni Rajeev Dhere S. S. Jadhav Heikki Peltola Mikko Paunio Suresh Jadhav Hitt Sharma Mrudula Phadke
Topics: Virology and Viral Diseases (10 papers)Vaccine Coverage and Hesitancy (8 papers)Bacterial Infections and Vaccines (8 papers)
Cited by: Health Microbiology Virology
Journals: PLoS ONE Clinical Infectious Diseases Virology
Partner nations: India United States Egypt

In The Last Decade

Subhash V. Kapre

21 papers receiving 409 citations

Peers

Countries citing papers authored by Subhash V. Kapre

Since Specialization

Citations

This map shows the geographic impact of Subhash V. Kapre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subhash V. Kapre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subhash V. Kapre more than expected).

Fields of papers citing papers by Subhash V. Kapre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subhash V. Kapre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subhash V. Kapre. The network helps show where Subhash V. Kapre may publish in the future.

Co-authorship network of co-authors of Subhash V. Kapre

This figure shows the co-authorship network connecting the top 25 collaborators of Subhash V. Kapre. A scholar is included among the top collaborators of Subhash V. Kapre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subhash V. Kapre. Subhash V. Kapre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer's Perspective From the Serum Institute of India 2015 ·Clinical Infectious Diseases ·Prasad S. Kulkarni,(unknown),Suresh Jadhav,Subhash V. Kapre,F. Marc LaForce,(unknown)	10
2	Technical Development of a New Meningococcal Conjugate Vaccine 2015 ·Clinical Infectious Diseases ·Carl E. Frasch,Subhash V. Kapre,Che‐Hung Lee,(unknown)	13
3	Isolation of a High Affinity Neutralizing Monoclonal Antibody against 2009 Pandemic H1N1 Virus That Binds at the ‘Sa’ Antigenic Site 2013 ·PLoS ONE ·(unknown),Vamsee Mallajosyula,(unknown),(unknown),Rajeev Dhere,Subhash V. Kapre,Raghavan Varadarajan,Gupta Sk	15
4	Antibody persistence of two pentavalent DTwP–HB–Hib vaccines to the age of 15–18 months, and response to the booster dose of quadrivalent DTwP–Hib vaccine 2012 ·Vaccine ·Hitt Sharma,Sangeeta Yadav,Sanjay Lalwani,Subhash V. Kapre,Suresh Jadhav,Sameer Parekh,Sonali Palkar,(unknown),Sunil Bahl,Rakesh Kumar,(unknown)	11
5	A phase III, randomized controlled study to assess the safety and immunogenicity of a semi-synthetic diphtheria, tetanus and whole-cell pertussis vaccine in Indian infants 2012 ·Vaccine ·Hitt Sharma,(unknown),(unknown),Subhash V. Kapre,Suresh Jadhav,(unknown),Rakesh Kumar,Sunil Bahl,Sameer Parekh,(unknown)	0
6	Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: A randomized, dose-escalation phase 1 study in adults 2012 ·Vaccine ·Nithya Gogtay,Urmila Thatte,Nilima Kshirsagar,Brett Leav,Deborah C. Molrine,Peter Cheslock,Subhash V. Kapre,Prasad S. Kulkarni	33
7	A phase III randomized, controlled study to assess the immunogenicity and tolerability of DTPw–HBV–Hib, a liquid pentavalent vaccine in Indian infants 2011 ·Vaccine ·Hitt Sharma,(unknown),Sanjay Lalwani,Vijay Gupta,Subhash V. Kapre,Suresh Jadhav,(unknown),Sameer Parekh,Sonali Palkar	15
8	A phase III randomized, controlled study to assess and compare the immunogenicity and tolerability of single and multi-dose vials of DTwP-Hib, a fully liquid quadravalent vaccine and their comparison with TETRAct-Hib vaccine in Indian infants aged 6–14 weeks 2011 ·Vaccine ·Hitt Sharma,(unknown),(unknown),(unknown),Subhash V. Kapre,Suresh Jadhav,(unknown),Sunil Bahl,Sameer Parekh,(unknown),(unknown),(unknown)	2
9	Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India 2011 ·The Journal of Infection in Developing Countries ·Hitt Sharma,V S Padbidri,Subhash V. Kapre,Suresh Jadhav,Rajeev Dhere,Sameer Parekh,(unknown),(unknown),(unknown)	26
10	Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children 2011 ·Human Vaccines ·Hitt Sharma,(unknown),Sanjay Lalwani,Subhash V. Kapre,Suresh Jadhav,(unknown),Sameer Parekh,Sonali Palkar,(unknown),(unknown),Vikas Verma	20
11	Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process 2011 ·Vaccine ·Hitt Sharma,(unknown),Sanjay Lalwani,Mamta Manglani,(unknown),Subhash V. Kapre,Suresh Jadhav,Sameer Parekh,(unknown),Nandini Malshe,Sonali Palkar,(unknown),(unknown),(unknown),(unknown)	10
12	No demonstrable association between the Leningrad–Zagreb mumps vaccine strain and aseptic meningitis in a large clinical trial in Egypt 2010 ·Clinical Microbiology and Infection ·Hitt Sharma,(unknown),(unknown),Subhash V. Kapre,S. S. Jadhav,Rajeev Dhere,(unknown)	8
13	Thermostable formulations of a hepatitis B vaccine and a meningitis A polysaccharide conjugate vaccine produced by a spray drying method 2010 ·Vaccine ·(unknown),Subhash V. Kapre,Akshay Goel,(unknown),(unknown),Julian Hickling,(unknown),Manjari Lal,(unknown),(unknown),Debra Kristensen	40
14	No demonstrable association between the Leningrad-Zagreb mumps vaccine strain and aseptic meningitis in a large clinical trial in Egypt 2009 ·Clinical Microbiology and Infection ·Hitt Sharma,(unknown),(unknown),Subhash V. Kapre,Suresh Jadhav,(unknown)	0
15	Immunogenicity of Two Modern Tissue Culture Rabies Vaccines in Pre-Exposure Prophylaxis 2007 ·Human Vaccines ·Prasad S. Kulkarni,(unknown),Suresh Jadhav,Subhash V. Kapre,(unknown)	3
16	Mumps Outbreaks in Canada and the United States: Time for New Thinking on Mumps Vaccines 2007 ·Clinical Infectious Diseases ·Heikki Peltola,Prasad S. Kulkarni,Subhash V. Kapre,Mikko Paunio,S. S. Jadhav,Rajeev Dhere	107
17	Mapping antigenic diversity and strain specificity of mumps virus: A bioinformatics approach 2006 ·Virology ·Urmila Kulkarni‐Kale,(unknown),(unknown),Deepti D. Deobagkar,(unknown),Rajeev Dhere,Subhash V. Kapre	27
18	Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults 2006 ·Vaccine ·P. R. Kulkarni,(unknown),Pralhad Sadashiv Patki,Mrudula Phadke,S. S. Jadhav,Subhash V. Kapre,(unknown),(unknown)	19
19	No definitive evidence for L-Zagreb mumps strain associated aseptic meningitis: a review with special reference to the da Cunha study 2005 ·Vaccine ·Prasad S. Kulkarni,Mrudula Phadke,S. S. Jadhav,Subhash V. Kapre	12
20	DNA vaccine for rabies: Relevance of the trans-membrane domain of the glycoprotein in generating an antibody response 2005 ·Virus Research ·Archana Rath,Sangeeta Choudhury,(unknown),Subhash V. Kapre,Charles E. Rupprecht,Gupta Sk	18

About Subhash V. Kapre

Subhash V. Kapre is a scholar working on Microbiology, Health and Infectious Diseases, having authored 24 papers that have together received 429 indexed citations. Recurring topics across this work include Virology and Viral Diseases (10 papers), Vaccine Coverage and Hesitancy (8 papers) and Bacterial Infections and Vaccines (8 papers). The work is most often cited by research in Health (123 citations), Microbiology (80 citations) and Virology (60 citations). Subhash V. Kapre has collaborated with scholars based in India, United States and Egypt. Frequent co-authors include Prasad S. Kulkarni, Rajeev Dhere, S. S. Jadhav, Heikki Peltola, Mikko Paunio, Suresh Jadhav, Hitt Sharma, Mrudula Phadke, Sameer Parekh and Gupta Sk. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact